
Thalidomide, Hydroxyurea Combination Bests Hydroxyurea Alone for Sickle Cell Anemia
Findings from a recent open-label quasi-experimental clinical trial conducted in India highlight the safety and efficacy of combined thalidomide and hydroxyurea (HU) for treating sickle cell anemia (SCA) versus HU alone.1 Although HU has been proven to …